Stephan Herzig

Stephan Herzig

pharmacologistMale0.0Global Dominance: 0.00%

Stephan Herzig is a pharmacologist at the Helmholtz Center Munich, where he studies metabolic processes and their implications on health. His research has contributed to the understanding of how fasting influences hormonal signals and cellular adaptations. Herzig's insights suggest that while intermittent fasting may offer short-term benefits, long-term adherence and weight management play crucial roles in sustaining health improvements.

Power0
Reach0
Collect

Not in the pool (under ¢1).

Recent news mentions

Stephan Herzig is a professor at TUM and director of the Institute for Diabetes and Cancer who commented on the risks of intermittent fasting for children and adolescents.

Digiuno intermittente: nei topi giovani ha interrotto lo sviluppo delle cellule beta del pancreas
Corriere della Sera·ItalyItaly· 2025-02-17
5.0

Stephan Herzig, a pharmacologist at the Helmholtz Center Munich, discusses the biological responses to fasting.

Intervallfasten – wann es wirklich gesund ist
Neue Zürcher Zeitung·SwitzerlandSwitzerland· 2025-02-14
5.0